World’s Best Bank for Advisory 2020: Morgan Stanley
Euromoney, is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024
Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
AwardsAwards for Excellence

World’s Best Bank for Advisory 2020: Morgan Stanley

In big, complex M&A deals, the firm’s main challenge is which side to work for.

World's Best Bank For Advisory: Morgan Stanley | Euromoney Awards for Excellence 2020

The pandemic may have put new M&A discussions on hold for now, but many strategic transactions already underway continued towards the finish line in the first half of 2020. Morgan Stanley was to the fore in the biggest, most complex, cross-border ones.

In May, AbbVie completed the acquisition of Allergan for $63 billion in cash and stock, after the US Federal Trade Commission (FTC) approved both sides’ agreement to dispose of certain Allergan assets. The three-two vote in favour came after a nine-month investigation that led some investors to doubt it would go ahead.

“It looks like a large standard pharma merger between two US-listed companies, but Allergan is domiciled in Ireland and subject to the Irish takeover code. So, as well as seeking FTC approval, we had to conduct all the valuation and structural negotiations according to Irish law,” says Colm Donlon, head of M&A for Europe, Middle East and Africa at Morgan Stanley, lead financial adviser to AbbVie.


Morgan Stanley had long been close to AbbVie, having advised on the company’s separation from Abbott Laboratories in 2013.

Gift this article